Johnson & Johnson (JNJ) Closes Intra-Cellular Therapies, Inc. (ITCI) Acquisition Apr 2, 2025 08:45AM
Mizuho Downgrades Intra-Cellular Therapies (ITCI) to Neutral Feb 24, 2025 05:46AM
Canaccord Genuity Downgrades Intra-Cellular Therapies (ITCI) to Hold Jan 30, 2025 09:06PM
Cantor Fitzgerald provides update on Biotechnology stocks Jan 29, 2025 09:12AM
Intra-Cellular Therapies (ITCI) spreader of March 130 calls and May 135 calls Jan 27, 2025 05:17AM
View Older Stories

Jan 21, 2025 04:16PM RBC Capital Downgrades Intra-Cellular Therapies (ITCI) to Sector Perform
Jan 13, 2025 11:45PM Piper Sandler Downgrades Intra-Cellular Therapies (ITCI) to Neutral
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Jan 13, 2025 09:54AM Morgan Stanley Downgrades Intra-Cellular Therapies (ITCI) to Equalweight
Jan 13, 2025 06:32AM Johnson & Johnson (JNJ) Acquires Intra-Cellular Therapies (ITCI) for $132/sh Cash or $14.6B
Jan 13, 2025 06:27AM J&J (JNJ) in Talks to Buy Intra-Cellular (ITCI) - Bloomberg
Jan 13, 2025 06:24AM Intra-Cellular Therapies (ITCI) PT Raised to $140 at Mizuho
Jan 10, 2025 02:36PM Intra-Cellular Therapies (ITCI) PT Raised to $118 at BofA Securities
Jan 2, 2025 01:02PM Piper Sandler Highlights NBIX, ITCI, ALKS, AXSM as High Conviction Ideas in Biotechnology
Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
Dec 19, 2024 11:16AM RBC Capital's Game Changers: 'Disruptive Forces in Biotech'
Nov 29, 2024 06:32AM Mizuho Reiterates Outperform Rating on Intra-Cellular Therapies (ITCI)
Nov 5, 2024 07:00AM Intra-Cellular Therapies (ITCI) Reports Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA
Oct 30, 2024 04:38PM Intra-Cellular Therapies (ITCI) PT Raised to $79 at Goldman Sachs
Oct 30, 2024 07:32AM Intra-Cellular Therapies (ITCI) Misses Q3 EPS by 7c ; Offers Guidance
Sep 6, 2024 02:54AM Piper Sandler Upgrades Intra-Cellular Therapies (ITCI) to Overweight
Aug 21, 2024 06:21AM Intra-Cellular Therapies (ITCI) PT Raised to $81 at JPMorgan
Aug 8, 2024 06:23AM Intra-Cellular Therapies (ITCI) PT Lowered to $106 at RBC Capital
Aug 7, 2024 07:41AM Intra-Cellular Therapies (ITCI) Appoints Sanjeev Narula as CFO
Aug 7, 2024 07:35AM Intra-Cellular Therapies (ITCI) Tops Q2 EPS by 3c ; Offers Guidance
Jul 30, 2024 07:17AM RBC's biotech survey shows investors more bearish vs. last time
Jul 23, 2024 07:25AM Intra-Cellular Therapies (ITCI) PT Raised to $79 at JPMorgan
Jul 22, 2024 07:43AM Intra-Cellular Therapies (ITCI) PT Raised to $100 at Needham
Jun 25, 2024 09:31AM UBS Downgrades Intra-Cellular Therapies (ITCI) to Neutral (earlier)
Jun 25, 2024 06:12AM RBC Capital Reiterates Outperform Rating on Intra-Cellular Therapies (ITCI), 'We remain buyers'
Jun 20, 2024 12:10PM Intra-Cellular Therapies (ITCI) PT Raised to $100 at Mizuho, 'Top Pick'
Jun 18, 2024 12:11PM Intra-Cellular Therapies (ITCI) PT Raised to $103 at RBC Capital
Jun 18, 2024 07:31AM Intra-Cellular Therapies (ITCI) Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Jun 10, 2024 05:38AM RBC Capital Reiterates Outperform Rating on Intra-Cellular Therapies (ITCI)
Jun 4, 2024 08:14AM PayPal and Oracle are new top picks at Mizuho
May 31, 2024 06:11AM RBC Capital Reiterates Outperform Rating on Intra-Cellular Therapies (ITCI)
May 7, 2024 12:44PM Intra-Cellular Therapies (ITCI) PT Lowered to $96 at RBC Capital
May 7, 2024 12:32PM JPMorgan on Intra-Cellular Therapies (ITCI): 'We continue to like ITCI stock'
May 7, 2024 08:00AM Jefferies Positive on Intra-Cellular Therapies (ITCI): 'We like the setup ahead of the second MDD readout in late-Q2'
May 7, 2024 07:33AM Intra-Cellular Therapies (ITCI) Tops Q1 EPS by 16c ; Offers Guidance
Apr 23, 2024 06:44AM Intra-Cellular Therapies (ITCI) PT Raised to $107 at Canaccord Genuity
Apr 22, 2024 05:34AM Intra-Cellular Therapies (ITCI) PT Raised to $96 at Mizuho
Apr 17, 2024 08:59PM Intra-Cellular Therapies (ITCI) Prices Public Offering of Common Stock
Apr 17, 2024 06:54AM Intra-Cellular Therapies (ITCI) PT Raised to $103 at Baird
Apr 17, 2024 05:13AM Intra-Cellular Therapies (ITCI) PT Raised to $91 at BofA Securities
Apr 16, 2024 04:07PM Intra-Cellular Therapies (ITCI) Announces Proposed $500M Share Offering
Apr 16, 2024 04:04PM Intra-Cellular Therapies (ITCI) Files Mixed Shelf
Apr 16, 2024 11:32AM Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
Apr 16, 2024 08:40AM Mizuho positive on Intra-Cellular Therapies (ITCI), 'potential for the stock to move even higher'
Apr 16, 2024 07:06AM Intra-Cellular Therapies (ITCI) to Resume Trading at 7:30 a.m.
Apr 16, 2024 07:01AM Intra-Cellular Therapies (ITCI) Reports Positive Phase 3 Topline Results from Study 501
Apr 16, 2024 06:55AM Intra-Cellular Therapies (ITCI) Halted, News Pending
Apr 4, 2024 08:08AM These 8 stocks are the latest additions to Mizuho's Top Picks list
Mar 19, 2024 08:32AM Intra-Cellular Therapies (ITCI) Announces Leadership Changes
Feb 22, 2024 07:35AM Intra-Cellular Therapies (ITCI) Tops Q4 EPS by 15c, provides guidance
View Older Stories